Apixaban reduces AF patients’ stroke risk compared with ASAAgent tested in atrial fibrillation patients who are unsuitable for warfarin therapy Younger stroke patients show evidence of previous damageUnder-50s who have had ‘silent’ strokes are at higher risk for another stroke; MRIs recommended for all young stroke patients Canadians urge world stroke agenda General public can help motivate prevention in others and be trained in rehab therapies Panel nixes study of controversial MS treatment Hitting the links for brain injury research Begin brain exercises early to slow mental decline CIHR panel nixes study of controversial MS treatment Advisory group doesn’t rule out future trial, when there’s adequate evidence Newest guidelines for managing risk of sepsis show clinical impact High physician compliance, decreased resource utilization seen in Toronto hospital Research funds directed at controversial MS theory Research Highlights: Treatment of choice for absence epilepsy A double-blind, randomized study aimed to determine which of three drugs was optimum as initial empirical monotherapy. First Previous 50 51 52 53 54 Next Last
